Synpromics - Ownership and Business Overview

Life ScienceCompany

Synpromics Ownership

Who owns Synpromics?

Synpromics is owned by Asklepios BioPharmaceutical. It was acquired on August 13, 2019.

Was Synpromics formerly PE-backed?

Yes. Synpromics was formerly owned by 1 private investor.

Synpromics Business Overview

Where is Synpromics headquartered?

Synpromics is headquartered in Edinburgh, United Kingdom.

What sector is Synpromics in?

Synpromics is a life science company.

When was Synpromics founded?

Synpromics was founded in 2010.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Synpromics Ltd.

Nine Edinburgh Bioquarter,
Edinburgh, EH16 4UX
United Kingdom,
+44 1316 585 301
www.synpromics.com

Synpromics Ltd. engages in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics, and intelligent data-driven design. Synpromics Ltd. has developed PromPT, its multi-dimensional bioinformatics database, that enables product-specific promoter design and selection empowering the next generation of cell and gene-based medicines and bioprocessing applications.


 Subscribe to unlock this and 207,877
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Synpromics

Life Science Companies , United Kingdom Companies